
We narrowed to 206 results for: ELL
-
Antibody#184197-rAbPurposeAnti-VDAC1 (Human) recombinant mouse monoclonal antibodyDepositorRecommended ApplicationsImmunohistochemistry and Western BlotReactivityHuman, Mouse, and RatSource SpeciesMouseIsotypeIgG2aTrial SizeAvailable to purchaseAvailable sinceJune 15, 2022AvailabilityIndustry, Academic Institutions, and Nonprofits
-
Antibody#180102-rAbPurposeAnti-Kvbeta2/KCNAB2 K+ channel (Mouse) recombinant mouse monoclonal antibodyDepositorRecommended ApplicationsImmunohistochemistry and Western BlotReactivityHuman, Mouse, Rat, and ZebrafishSource SpeciesMouseIsotypeIgG2aTrial SizeAvailable to purchaseAvailable sinceMarch 30, 2022AvailabilityIndustry, Academic Institutions, and Nonprofits
-
Antibody#184202-rAbPurposeAnti-GIT1 (Rat) recombinant mouse monoclonal antibodyDepositorRecommended ApplicationsImmunohistochemistry and Western BlotReactivityHuman, Mouse, and RatSource SpeciesMouseIsotypeIgG2aTrial SizeAvailable to purchaseAvailable sinceAug. 22, 2022AvailabilityIndustry, Academic Institutions, and Nonprofits
-
Antibody#180082-rAbPurposeAnti-PSD-95 (Human) recombinant mouse monoclonal antibodyDepositorRecommended ApplicationsImmunohistochemistry and Western BlotReactivityHuman, Mouse, and RatSource SpeciesMouseIsotypeIgG2aTrial SizeAvailable to purchaseAvailable sinceMarch 30, 2022AvailabilityIndustry, Academic Institutions, and Nonprofits
-
Antibody#180086-rAbPurposeAnti-Kv1.2 K+ channel (Human) recombinant mouse monoclonal antibodyDepositorRecommended ApplicationsImmunohistochemistry and Western BlotReactivityFrog, Human, Mouse, Rat, and ZebrafishSource SpeciesMouseIsotypeIgG2aTrial SizeAvailable to purchaseAvailable sinceMarch 28, 2022AvailabilityIndustry, Academic Institutions, and Nonprofits
-
Antibody#184172-rAbPurposeAnti-GluA2/GluR2 glutamate receptor (Rat) recombinant mouse monoclonal antibodyDepositorRecommended ApplicationsImmunohistochemistry and Western BlotReactivityHuman, Mouse, and RatSource SpeciesMouseIsotypeIgG2aTrial SizeAvailable to purchaseAvailable sinceMay 31, 2022AvailabilityIndustry, Academic Institutions, and Nonprofits